GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Talphera Inc (STU:R5XA) » Definitions » Price-to-Funds-From-Operations

Talphera (STU:R5XA) Price-to-Funds-From-Operations : (As of Jun. 09, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Talphera Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


Talphera (STU:R5XA) Business Description

Industry
Traded in Other Exchanges
Address
25821 Industrial Boulevard, Suite 400, Hayward, CA, USA, 94545
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings. Its product portfolio includes Niyad that is a lyophilized formulation of nafamostat. It is also developing two pre-filled syringes, a pre-filled ephedrine syringe, and PFS-02, a pre-filled phenylephrine syringe.